Abstract
BackgroundHyperkalaemia occurs in up to 10% of hospital admissions but its treatment in the emergency setting is inconsistent. ObjectivesTo describe the emergency management of hyperkalaemia in adults with insulin-dextrose (IDex) and to explore clinical outcomes associated with IDex treatment. Design and settingCohort study using comprehensive electronic health records of all emergency admissions to a large university hospital in the United Kingdom between April 2015 and August 2018. ParticipantsAdult patients aged ≥16 years with at least one emergency admission and one blood potassium result during the study period. Main outcomes and measuresEmergency hyperkalaemia treatment was evaluated including the requirement for re-treatment with IDex, episodes of glucose dysregulation, intensive care (ICU) admission and length of hospital stay. Associations with hyperkalaemia, adverse events and IDex treatment were explored by logistic regression. ResultsAmongst 211,993 patients attending the Emergency Department (ED) we identified 11,107 hyperkalaemic adult patients, of whom 1,284 were treated with IDex.Multiple doses were required in 542 patients (42.2%). Hypoglycaemia (plasma glucose < 4 mmol/L) occurred in 249 patients (19.4%) within 6 hours of IDex. Repeated doses were associated with an increased risk of hypoglycaemia (OR 2.94, 95% CI 2.20 to 3.93) compared to patients receiving a single dose, which, after adjustment was also associated with an increased risk of death (OR 1.56, 95% CI 1.16 to 2.09) during the study period.Patients who received multiple doses of IDex (OR 2.2, 95% CI 1.6-3.1) and those who received a dose of insulin above the guideline recommended limit (OR 5.6 3.1-10.3) were more likely to be admitted to ICU following IDex than those who received a single dose or the guideline recommended dose of insulin. Conclusions and RelevanceThis study provides novel insight into the emergency management of hyperkalaemia in a large population, demonstrates the high risk of hypoglycaemia and highlights the urgent need for an improved, evidence-based approach to the emergency management of hyperkalaemia.
Highlights
Hyperkalaemia is a common, life-threatening electrolyte abnormal ity present in up to 10% of acute hospital admissions [1]
The second objective focussed on clinical outcomes relating to treatment effectiveness, safety and healthcare resource use amongst hyperkalaemic patients treated with IDex in comparison with patients with confirmed moderate-severe hyperkalaemia who did not receive IDex
Our results show that emergency treatment of hyperkalaemia varied and in patients treated with IDex, a single dose was insufficient in 4 out of 10 patients, was associated with a risk of hypoglycaemia in 20% of patients and resulted in an increased length of hospital stay compared to hyperkalaemic patients not treated with IDex
Summary
Hyperkalaemia is a common, life-threatening electrolyte abnormal ity present in up to 10% of acute hospital admissions [1]. Hyperkalaemia can result in fatal cardiac arrhythmias if not treated promptly It typically requires in-hospital treatment and constitutes a medical emergency. Hyperkalaemia occurs in up to 10% of hospital admissions but its treatment in the emergency setting is inconsistent. Objectives: To describe the emergency management of hyperkalaemia in adults with insulin-dextrose (IDex) and to explore clinical outcomes associated with IDex treatment. Design and setting: Cohort study using comprehensive electronic health records of all emergency admissions to a large university hospital in the United Kingdom between April 2015 and August 2018. Participants: Adult patients aged ≥16 years with at least one emergency admission and one blood potassium result during the study period. Main outcomes and measures: Emergency hyperkalaemia treatment was evaluated including the requirement for re-treatment with IDex, episodes of glucose dysregulation, intensive care (ICU) admission and length of hospital stay. Conclusions and Relevance: This study provides novel insight into the emergency management of hyperkalaemia in a large population, demonstrates the high risk of hypoglycaemia and highlights the urgent need for an improved, evidence-based approach to the emergency management of hyperkalaemia
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
